Benjamin Hall
Associate Director, Analytical Development Tessera Therapeutics
Seminars
Thursday 3rd December 2026
Improving LNP Potency Assay Robustness to Enable Reliable QC Transfer
4:15 pm
- Understanding regulatory expectations shaping potency assay design and validation
- Anticipating transfer requirements when developing mRNA LNP assays for future QC
- use
- Comparing base and targeted LNP approaches to inform robust assay development
